NFKBIA and cancer: We find that oncogenic NRAS, KRAS, and HRAS activate the expression of IkappaBalpha (IκBα) and BAY 11-7082, an inhibitor of IκBα kinase, attenuates the growth of NRAS, KRAS, and HRAS mutant cancer cells in cell culture and in vivo mouse model.